Connection

Lucinda Halstead to Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18

Back to Details
This is a "connection" page, showing publications Lucinda Halstead has written about Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18.
Lucinda Halstead
Connection Strength
0.495
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  1. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma. J Voice. 2015 Mar; 29(2):223-9.
    View in: PubMed
    Score: 0.495
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.